AbbVie Inc (BUE:ABBV)
ARS 21100 275 (1.32%) Market Cap: 326.28 Til Enterprise Value: 391.76 Til PE Ratio: 63.33 PB Ratio: 53.42 GF Score: 74/100

Abbvie Inc at Evercore ISI HealthCONx Virtual Conference Transcript

Dec 02, 2021 / 05:10PM GMT
Joshua Elliott Schimmer
Evercore ISI Institutional Equities, Research Division - Senior MD & Equity Analyst

All right. Welcome, everyone. It's Josh Schimmer from the Evercore ISI Biotech team. We're very pleased to introduce from AbbVie, we have Mike Severino, Vice Chairman and President; we have Rob Michael, Chief Financial Officer; Jeff Stewart, Executive Vice President of Commercial Operations; and also joined by Carrie Strom, President of Global Allergan Aesthetics. So got the whole team and a lot of ground to cover.

Questions & Answers

Joshua Elliott Schimmer;Michael E. Severino
Evercore ISI Institutional Equities, Research Division - Senior MD & Equity Analyst;AbbVie Inc. - Vice

I'm going to start with the question really just to get it out of the way, why is everyone asking me about this AbbVie CF? Like it's the only topic that I get questions on. You may feel the same. Why is everyone still fixated on this? And what should we be looking for in the months or weeks or months ahead from the program?

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot